Operating loss was $0.14 per share for the March quarter, flat with the year-ago period, whereas Q1 sales increased to $28.2 million, from $26.4 million. No analyst estimates were available for comparison.
Price: 4.1200, Change: +0.0600, Percent Change: +1.48
|Analyst Actions: Jefferies Initiates Coverage on LPL...|
|Otonomy Begins Phase 1/2 Study of Hearing Loss Treat...|
|Axon Launches VR Empathy Training for Suicide Preven...|
|Analyst Actions: Deutsche Bank Initiates Coverage on...|
|Analyst Actions: Citigroup Initiates Coverage on IAC...|